NASDAQ

Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares (KNSA)

♥ 539 Thanks from members

Live price chart, market sentiment, and community perspectives for Kiniksa Pharmaceuticals International, plc (NASDAQ: KNSA).

Member Opinions and Insights

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →
Entity and Market Metadata
Sector: HealthcareIndustry: BiotechnologyFounder: SynconaFounder: AccelRxLeadership: Robert J. Bujarski (President and CEO)Holder: Syncona Ltd.Holder: FMR LLCHolder: BlackRock, Inc.Arcalyst (rilonacept)KPL-716Mavrilimumab#Kiniksa Pharmaceuticals#KNSA stock#biotech company#Arcalyst#immunology therapeutics